Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels

Frank M. Sacks, Jean Lucien Rouleau, Lemuel A. Moye, Marc A. Pfeffer, J. Wayne Warnica, J. Malcolm O Arnold, David T. Nash, Lisa E. Brown, Francois Sestier, John Rutherford, Barry R. Davis, C. Morton Hawkins, Eugene Braunwald, CARE Investigators The CARE Investigators

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

CARE will determine whether 5 years of cholesterol-lowering therapy reduces recurrent coronary disease events in 4,159 patients who have had an AMI. The mean total cholesterol and LDL-C levels in CARE (209 and 139 mg/dl) are similar to the average levels for the US population. The results of CARE will have relevance to the treatment of the majority of patients with coronary disease who have average rather than elevated cholesterol levels.

Original languageEnglish (US)
Pages (from-to)621-623
Number of pages3
JournalThe American Journal of Cardiology
Volume75
Issue number8
DOIs
StatePublished - Mar 15 1995

Fingerprint

Secondary Prevention
Cholesterol
Serum
Coronary Disease
Hypercholesterolemia
LDL Cholesterol
Therapeutics
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sacks, F. M., Rouleau, J. L., Moye, L. A., Pfeffer, M. A., Warnica, J. W., Arnold, J. M. O., ... The CARE Investigators, CARE. I. (1995). Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels. The American Journal of Cardiology, 75(8), 621-623. https://doi.org/10.1016/S0002-9149(99)80631-6

Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels. / Sacks, Frank M.; Rouleau, Jean Lucien; Moye, Lemuel A.; Pfeffer, Marc A.; Warnica, J. Wayne; Arnold, J. Malcolm O; Nash, David T.; Brown, Lisa E.; Sestier, Francois; Rutherford, John; Davis, Barry R.; Hawkins, C. Morton; Braunwald, Eugene; The CARE Investigators, CARE Investigators.

In: The American Journal of Cardiology, Vol. 75, No. 8, 15.03.1995, p. 621-623.

Research output: Contribution to journalArticle

Sacks, FM, Rouleau, JL, Moye, LA, Pfeffer, MA, Warnica, JW, Arnold, JMO, Nash, DT, Brown, LE, Sestier, F, Rutherford, J, Davis, BR, Hawkins, CM, Braunwald, E & The CARE Investigators, CAREI 1995, 'Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels', The American Journal of Cardiology, vol. 75, no. 8, pp. 621-623. https://doi.org/10.1016/S0002-9149(99)80631-6
Sacks, Frank M. ; Rouleau, Jean Lucien ; Moye, Lemuel A. ; Pfeffer, Marc A. ; Warnica, J. Wayne ; Arnold, J. Malcolm O ; Nash, David T. ; Brown, Lisa E. ; Sestier, Francois ; Rutherford, John ; Davis, Barry R. ; Hawkins, C. Morton ; Braunwald, Eugene ; The CARE Investigators, CARE Investigators. / Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels. In: The American Journal of Cardiology. 1995 ; Vol. 75, No. 8. pp. 621-623.
@article{87f3bcfe31c041839727e0bc86b13926,
title = "Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels",
abstract = "CARE will determine whether 5 years of cholesterol-lowering therapy reduces recurrent coronary disease events in 4,159 patients who have had an AMI. The mean total cholesterol and LDL-C levels in CARE (209 and 139 mg/dl) are similar to the average levels for the US population. The results of CARE will have relevance to the treatment of the majority of patients with coronary disease who have average rather than elevated cholesterol levels.",
author = "Sacks, {Frank M.} and Rouleau, {Jean Lucien} and Moye, {Lemuel A.} and Pfeffer, {Marc A.} and Warnica, {J. Wayne} and Arnold, {J. Malcolm O} and Nash, {David T.} and Brown, {Lisa E.} and Francois Sestier and John Rutherford and Davis, {Barry R.} and Hawkins, {C. Morton} and Eugene Braunwald and {The CARE Investigators}, {CARE Investigators}",
year = "1995",
month = "3",
day = "15",
doi = "10.1016/S0002-9149(99)80631-6",
language = "English (US)",
volume = "75",
pages = "621--623",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels

AU - Sacks, Frank M.

AU - Rouleau, Jean Lucien

AU - Moye, Lemuel A.

AU - Pfeffer, Marc A.

AU - Warnica, J. Wayne

AU - Arnold, J. Malcolm O

AU - Nash, David T.

AU - Brown, Lisa E.

AU - Sestier, Francois

AU - Rutherford, John

AU - Davis, Barry R.

AU - Hawkins, C. Morton

AU - Braunwald, Eugene

AU - The CARE Investigators, CARE Investigators

PY - 1995/3/15

Y1 - 1995/3/15

N2 - CARE will determine whether 5 years of cholesterol-lowering therapy reduces recurrent coronary disease events in 4,159 patients who have had an AMI. The mean total cholesterol and LDL-C levels in CARE (209 and 139 mg/dl) are similar to the average levels for the US population. The results of CARE will have relevance to the treatment of the majority of patients with coronary disease who have average rather than elevated cholesterol levels.

AB - CARE will determine whether 5 years of cholesterol-lowering therapy reduces recurrent coronary disease events in 4,159 patients who have had an AMI. The mean total cholesterol and LDL-C levels in CARE (209 and 139 mg/dl) are similar to the average levels for the US population. The results of CARE will have relevance to the treatment of the majority of patients with coronary disease who have average rather than elevated cholesterol levels.

UR - http://www.scopus.com/inward/record.url?scp=0028912054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028912054&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(99)80631-6

DO - 10.1016/S0002-9149(99)80631-6

M3 - Article

C2 - 7887392

AN - SCOPUS:0028912054

VL - 75

SP - 621

EP - 623

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 8

ER -